PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation
NCT: NCT07765238 · NOT_YET_RECRUITING
Brief Summary
This prospective randomized pilot study evaluates the feasibility, acceptability, and preliminary efficacy of the Patient-Controlled Dispenser and Deactivator (PCDD) Generation 1 system for patient-controlled oral liquid acetaminophen administration in postoperative total shoulder replacement inpatients compared with standard nurse-administered oral acetaminophen delivery.
Frequently Asked Questions
What is PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation?
PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation is a clinical trial registered under NCT07765238. Current status: NOT_YET_RECRUITING.
What is the status of NCT07765238?
The current status of NCT07765238 (PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation) is: NOT_YET_RECRUITING.
When did PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation start?
PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.